Considering the key role of IL-17 and IL-23 cytokines in both the immunopathogenesis of psoriasis and the development of psychiatric symptoms such as depression and anxiety, future studies should investigate the potential benefits of biologic therapies targeting these pathways. This evidence concerns the gene IL17A and major depressive disorder.